Studied at Frankfurt/M. University, and holds a Diploma in Chemistry and Ph.D. in Biochemistry. After his postdoc in the US he started his industrial career at Hoechst Pharma and Corporate Research. Then he moved to Henkel as VP Enzyme Technology. After spending three years in the Venture Capital industry, he joined the management board of Protagen where he served as CEO until 2016. Stefan developed highly specialized biotech service businesses to global technology leadership, and now supports technology companies and investors to identify the most attractive products and service businesses for a successful business strategy.